Atlas Trials

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

Clinical trial NCT02908347 · COMPLETED

Trial details

NCT number
NCT02908347
Sponsor
MetrioPharm AG
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
PsoriasisPlaque Psoriasis
Start date
2016-05-01
Primary completion
2016-12-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.